EoE KIDS: Higher Exposure Dupilumab Improves Histologic, Endoscopic Outcomes
Higher exposure dupilumab significantly improved histologic and endoscopic outcomes in children with EoE aged 1 to <12 years.
Mirna Chehade Drug Administration Mount Sinai Digestive Disease Week Improves Histologic Endoscopic Outcomes
Source: hcplive.com